{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-010538","form_type":"8-K","ticker":"SKIN","cik":"0001818093","company_name":"SkinHealth Systems Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.665309+00:00","generated_at":"2026-06-04T23:14:17.155853+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BeautyHealth Q4 net sales $96.8M (-1.3% YoY); full year net loss $100.1M","bullets":["Full year net sales $398.0M, up 8.8% YoY; Q4 net sales $96.8M, down 1.3% YoY.","Full year net loss $100.1M (vs $44.2M income in 2022); Q4 net loss $9.4M (vs $6.5M income).","Full year adjusted EBITDA $24.3M (6.1% margin) vs $46.1M (12.6% margin) in 2022.","Total delivery systems sold in Q4 1,551 vs 2,067 YoY; active install base grew 24% to 31,446.","Adjusted gross margin fell to 54.6% in Q4 from 73.6% in prior year; full year 62.8% vs 72.6%."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-010538","json":"https://secwatch.observer/filing/0001628280-24-010538.json","markdown":"https://secwatch.observer/filing/0001628280-24-010538.md","text":"https://secwatch.observer/filing/0001628280-24-010538.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/0001628280-24-010538-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/skin-20240312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:14:17.155853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"24ef4c190ff2ed25612570aeaa4ddadc9905d317","claim":"SkinHealth Systems Inc. reported the fiscal year ended December 31, 2023 results: revenue $398.0 million, net income $(100.1) million.","evidence_excerpt":"with its disclosure obligations under Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ:","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/0001628280-24-010538-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$398.0 million"},{"label":"Net income","value":"$(100.1) million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"47bc954876888e4c590e5714c2da7eab46dd9e3e","claim":"SkinHealth Systems Inc. reported the fourth quarter ended December 31, 2023 results: revenue $96.8 million, net income $(9.4) million.","evidence_excerpt":"Regulation FD. --- EX-99.1 (EX-99.1) --- BeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Beach, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth”), home to","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024010538/0001628280-24-010538-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$96.8 million"},{"label":"Net income","value":"$(9.4) million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}